Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.
about
Direct interaction of the human I-mfa domain-containing protein, HIC, with HIV-1 Tat results in cytoplasmic sequestration and control of Tat activityHuman DDX3 interacts with the HIV-1 Tat protein to facilitate viral mRNA translationThe cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNASpt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequencesAcetylation of histones and transcription-related factorsRepression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factorsTAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulationCoordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcriptionSp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat proteinTat-dependent occlusion of the HIV poly(A) siteHuman immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complexHIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox stateRelatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufenIdentification of a minimal region of the HIV-1 5'-leader required for RNA dimerization, NC binding, and packagingProteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity: identification of a repeated basic amino acid motif within the C-terminal binding regionStructural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysisVisna virus Tat protein: a potent transcription factor with both activator and suppressor domainsComparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virusFunctional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeatIn vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factorRecruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cellsHIV-1 Tat interacts with LIS1 proteinMonitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMRTat gets the "green" light on transcription initiationSolution Structure of a Designed Spirocyclic Helical Ligand Binding at a Two-Base Bulge Site in DNA †Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulgeA 1.3-A resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformationNUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoterIdentification of a group of cellular cofactors that stimulate the binding of RNA polymerase II and TRP-185 to human immunodeficiency virus 1 TAR RNATat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcriptionFunctional interaction between the HIV transactivator Tat and the transcriptional coactivator PC4 in T cellsModulation of WHSC2 expression in human endothelial cellsThe nuclear receptor chicken ovalbumin upstream promoter transcription factor interacts with HIV-1 Tat and stimulates viral replication in human microglial cellsTFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcriptionTat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replicationDifferential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunctionRequirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexesRational optimization of a HIV-1 Tat inhibitor: rapid progress on combinatorial lead structuresInhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro
P2860
Q24293249-5EF1A8CC-8FD8-40EA-9933-60CC6C53ABB3Q24307731-8CD18CB8-58A2-407E-BE95-57251CD28A65Q24312742-DF696845-9706-47F9-8A80-F61DBB080AA4Q24537527-84D41D2F-74D2-496F-97DD-970B14ED48C9Q24548503-812F8212-09F8-4C64-8AEE-8FE77D488B0BQ24550742-9BAC4D84-F3BF-49C0-95BF-A11A63E472E6Q24555668-9A614BFE-CB4F-4FD8-B1C9-5F776153AE35Q24559797-8004BB56-17DE-4430-BCF9-B8EE07CC9146Q24561778-1B00B48D-0346-4D45-A983-0EAFA89C8A35Q24564637-D981F2DA-D2A3-456E-A87A-4C8B6ACDC4CBQ24568316-AC482FFF-BB1C-4ADC-A34B-3AB392496897Q24568360-1AAD398A-8420-4060-B195-A8C87CDF42E2Q24606166-799E0CDA-75AC-44D8-A5D7-FC07D89ECC92Q24622200-A552B703-F634-4D55-BF43-DE0CD948F588Q24630433-9F760EB4-F028-4088-AD78-0280223C74DBQ24630462-582BD03F-6900-429F-A64B-7E8B5AD47E6AQ24645727-99B0F929-4781-49C3-8B0F-8E5FDC722961Q24646050-33202DE4-7507-470A-AB3A-F3F039D03670Q24655684-61CEC7BC-9F40-45BE-8198-080461D581CDQ24655901-4F90EB91-6686-43DC-A781-0FF6B592B46DQ24679559-BB6C55AD-3B20-43FF-A746-CC8BF00D7C20Q24807276-3BA93240-4757-4804-B92C-FB808BEB08C9Q24810413-8D178EEC-B823-4850-9C76-8B71035A02D2Q24815711-4E327507-D5DC-41F2-9719-0F7E86EF07E3Q27644249-E97DC2C5-47BC-4836-B69E-D1C75084C56EQ27733920-57D8A7F5-A589-4BCA-ABCC-879B6B8E2953Q27765139-002A429D-8C6E-4061-AE85-EA92F07C4566Q28115345-69C4A564-400D-4F8E-B832-9E3840C8314BQ28116110-B03975EE-EF86-4567-80B8-E3BCBFA0E039Q28116305-CFC86FAC-4484-4F4F-90B8-7B035C2CC196Q28140346-E09ACD4C-A26B-4FAD-8C12-AEF6983D27E0Q28142268-BBABB890-FC73-41E8-83B4-889ADE9B3503Q28143137-D0261AEB-58C9-4F1F-98E4-23E83590ADD0Q28188877-3A3F29B6-608A-4E1B-B816-3436F689B451Q28214887-ED66B9B3-5C33-4907-98AD-DA1405D42493Q28236758-D2CECCC6-2816-4BB0-BAD4-CC851B03197DQ28296237-D90F51A9-351F-4DD6-B07D-A4571E94F456Q28304889-4558108A-75D4-4110-AE7A-E4A3B8D9A2ADQ28368863-882BF69E-1B99-4633-AE73-2AE8D20EC5CFQ28378556-3E351065-83D1-49FF-BA9C-36E2C70F4F19
P2860
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.
description
1989 nî lūn-bûn
@nan
1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Human immunodeficiency virus 1 ...... ive region (TAR) RNA in vitro.
@ast
Human immunodeficiency virus 1 ...... ive region (TAR) RNA in vitro.
@en
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region
@nl
type
label
Human immunodeficiency virus 1 ...... ive region (TAR) RNA in vitro.
@ast
Human immunodeficiency virus 1 ...... ive region (TAR) RNA in vitro.
@en
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region
@nl
prefLabel
Human immunodeficiency virus 1 ...... ive region (TAR) RNA in vitro.
@ast
Human immunodeficiency virus 1 ...... ive region (TAR) RNA in vitro.
@en
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region
@nl
P2093
P2860
P356
P1476
Human immunodeficiency virus 1 ...... ive region (TAR) RNA in vitro.
@en
P2093
Dingwall C
Skinner MA
P2860
P304
P356
10.1073/PNAS.86.18.6925
P407
P577
1989-09-01T00:00:00Z